Areteia Therapeutics
Areteia Therapeutics is a startup headquartered in Chapel Hill, United States, founded in 2022. It has raised at least $360.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Areteia Therapeutics has raised at least $360.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Areteia Therapeutics sits inside the Durham region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Chapel Hill
Related
- Innovation profile of Chapel Hill
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Areteia Therapeutics do?
Areteia Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Areteia Therapeutics raised?
At least $360.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Areteia Therapeutics based?
Areteia Therapeutics is headquartered in Chapel Hill, United States.
When was Areteia Therapeutics founded?
Areteia Therapeutics was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.